Accession Number: | 0001209191-22-035864 |
Date: | 2022-06-09 |
Issuer: | REGULUS THERAPEUTICS INC. (RGLS) |
Original Submission Date: |
SIMEONIDIS SIMOS
C/O REGULUS THERAPEUTICS
4224 CAMPUS POINT COURT #210
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.27 | 2022-06-09 | deemed execution date | A | 90,000 (a) | 2032-06-09 | common stock 90,000 | $0.27 | 90,000 | direct |
ID | footnote |
---|---|
f1 | pursuant to the company's non employee director's compensation policy, the options are automatically granted on the date of the company's annual meeting of stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the company's next annual stockholder meeting, whichever occurs first, subject to the reporting person's continuous service. |